No retraction, correction or concern found when last checked on Oct 17, 2026.

Structures of α-synuclein filaments from human brains with Lewy pathology

Yang Yang, Yang Shi, Manuel Schweighauser and 17 more

Nature · 2022

doi:10.1038/s41586-022-05319-3

Read free

References 66

1.
Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease · 2014
No notice
2.
Goedert M, Spillantini MG, Del Tredici K, Braak H. 100 years of Lewy pathology. Nature Rev Neurol. 2013;9:13-24.
Not in our library10.1038/nrneurol.2012.242
3.
Aarsland D, Andersen K, Larsen JP, Lolk A, Kragh-Sørensen P. Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Arch Neurol. 2003;60:387-392.
Not in our library10.1001/archneur.60.3.387
4.
Diagnosis and management of dementia with Lewy bodies · 2017
No notice
5.
Fanciulli A, Wenning GK. Multiple system atrophy. N Engl J Med. 2015;372:249-263.
Not in our library10.1056/nejmra1311488
6.
Schweighauser M, et al. Structures of α-synuclein filaments from multiple system atrophy. Nature. 2020;585:464-469.
Not in our library10.1038/s41586-020-2317-6
7.
Polymeropoulos MH, et al. Mutation in the α-synuclein gene identified in families with Parkinson’s disease. Science. 1997;276:2045-2047.
Not in our library10.1126/science.276.5321.2045
8.
Singleton AB, et al. α-Synuclein locus triplication causes Parkinson’s disease. Science. 2003;302:841.
Not in our library10.1126/science.1090278
9.
Zarranz JJ, et al. The new mutation, E46K, of alpha-synuclein causes Parkinson’s disease and Lewy body dementia. Ann Neurol. 2004;55:164-173.
Not in our library10.1002/ana.10795
10.
Nalls MA, et al. Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson’s disease. Nature Genet. 2014;46:989-993.
Not in our library10.1038/ng.3043
11.
Davidson WS, Jonas A, Clayton DF, George JM. Stabilization of α-synuclein secondary structure upon binding to synthetic membranes. J Biol Chem. 1998;273:9443-9449.
Not in our library10.1074/jbc.273.16.9443
12.
Ueda K, et al. Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. Proc Natl Acad Sci USA. 1993;90:11282-11286.
Not in our library10.1073/pnas.90.23.11282
13.
Li HT, Du HN, Tang L, Hu J, Hu HY. Structural transformation and aggregation of human α-synuclein in trifluoroethanol: non-amyloid component sequence is essential and β-sheet formation is prerequisite to aggregation. Biopolymers. 2002;64:221-226.
Not in our library10.1002/bip.10179
14.
Crowther RA, Jakes R, Spillantini MG, Goedert M. Synthetic filaments assembled from C-terminally truncated α-synuclein. FEBS Lett. 1998;436:309-312.
Not in our library10.1016/s0014-5793(98)01146-6
15.
Conway KA, Harper JD, Lansbury PT. Fibrils formed in vitro from α-synuclein and two mutant forms linked to Parkinson’s disease are typical amyloid. Biochemistry. 2000;39:2525-2563.
Not in our library10.1021/bi991447r
16.
Serpell LC, Berriman J, Jakes R, Goedert M, Crowther RA. Fiber diffraction of synthetic α-synuclein filaments shows amyloid-like cross-ß conformation. Proc Natl Acad Sci USA. 2000;97:4897-4902.
Not in our library10.1073/pnas.97.9.4897
17.
Miake H, Mizusawa H, Iwatsubo T, Hasegawa M. Biochemical characterization of the core structure of α-synuclein filaments. J Biol Chem. 2002;277:19213-19219.
Not in our library10.1074/jbc.m110551200
18.
Mougenot AL, et al. Prion-like acceleration of a synucleinopathy in a transgenic mouse model. Neurobiol Aging. 2012;33:2225-2228.
Not in our library10.1016/j.neurobiolaging.2011.06.022
19.
Luk KC, et al. Pathological α-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science. 2012;338:949-953.
Not in our library10.1126/science.1227157
20.
Masuda-Suzukake M, et al. Prion-like spreading of pathological α-synuclein in brain. Brain. 2013;136:1128-1138.
Not in our library10.1093/brain/awt037
21.
Osterberg VR, et al. Progressive aggregation of α-synuclein and selective degeneration of Lewy inclusion-bearing neurons in a mouse model of parkinsonism. Cell Rep. 2015;10:1252-1260.
Not in our library10.1016/j.celrep.2015.01.060
22.
Peelaerts W, et al. α-Synuclein strains cause distinct synucleinopathies after local and systemic administration. Nature. 2015;522:340-344.
Not in our library10.1038/nature14547
23.
Peng C, et al. Cellular milieu imparts pathological α-synuclein strains in α-synucleinopathies. Nature. 2018;557:558-563.
Not in our library10.1038/s41586-018-0104-4
24.
Prusiner SB, et al. Evidence for α-synuclein prions causing multiple system atrophy in humans with parkinsonism. Proc Natl Acad Sci USA. 2015;112:E5308-E5317.
Not in our library10.1073/pnas.1514475112
25.
Tarutani A, Arai T, Murayama S, Hisanaga SI, Hasegawa M. Potent prion-like behaviors of pathogenic α-synuclein and evaluation of inactivation methods. Acta Neuropathol Commun. 2018;6:29.
Not in our library10.1186/s40478-018-0532-2
26.
Parkinson’s disease and multiple system atrophy have distinct α-synuclein seed characteristics · 2019
No notice
27.
Silver staining (Campbell-Switzer) of neuronal α-synuclein assemblies induced by multiple system atrophy and Parkinson’s disease brain extracts in transgenic mice · 2019
Not checked
28.
Klingstedt T, et al. Luminescent conjugated oligothiophenes distinguish between α-synuclein assemblies of Parkinson’s disease and multiple system atrophy. Acta Neuropathol Commun. 2019;7:193.
Not in our library10.1186/s40478-019-0840-1
29.
Structural heterogeneity of α-synuclein fibrils amplified from patient brain extracts · 2019
No notice
30.
Lau A, et al. α-Synuclein strains target distinct brain regions and cell types. Nature Neurosci. 2020;23:21-31.
Not in our library10.1038/s41593-019-0541-x
31.
Shahnawaz M, et al. Discriminating α-synuclein strains in Parkinson’s disease and multiple system atrophy. Nature. 2020;578:273-277.
Not in our library10.1038/s41586-020-1984-7
32.
Ayers JI, et al. Different α-synuclein prion strains cause dementia with Lewy bodies and multiple system atrophy. Proc Natl Acad Sci USA. 2022;119:e2113489119.
Not in our library10.1073/pnas.2113489119
33.
Spillantini MG, Crowther RA, Jakes R, Hasegawa M, Goedert M. α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodies. Proc Natl Acad Sci USA. 1998;95:6469-6473.
Not in our library10.1073/pnas.95.11.6469
34.
Crowther RA, Daniel SE, Goedert M. Characterisation of isolated α-synuclein filaments from substantia nigra of Parkinson’s disease brain. Neurosci Lett. 2000;292:128-130.
Not in our library10.1016/s0304-3940(00)01440-3
35.
Holec SAM, Liu SL, Woerman AL. Consequences of variability in α-synuclein fibril structure on strain biology. Acta Neuropathol. 2022;143:311-330.
Not in our library10.1007/s00401-022-02403-w
36.
Zhao K, et al. Parkinson’s disease-related phosphorylation at Tyr39 rearranges α-synuclein amyloid fibril structure revealed by cryo-EM. Proc Natl Acad Sci USA. 2020;117:20305-20315.
Not in our library10.1073/pnas.1922741117
37.
McGlinchey RP, Ni X, Shadish JA, Jiang J, Lee JC. The N-terminus of α-synuclein dictates fibril formation. Proc Natl Acad Sci USA. 2021;118:e2023487118.
Not in our library10.1073/pnas.2023487118
38.
Two new polymorphic structures of human full-length alpha-synuclein fibrils solved by cryo-electron microscopy · 2019
No notice
39.
Shi Y, et al. Structure-based classification of tauopathies. Nature. 2021;598:359-363.
Not in our library10.1038/s41586-021-03911-7
40.
Tsuboi Y, Dickson DW. Dementia with Lewy bodies and Parkinson’s disease with dementia: Are they different? Parkinsonism Relat. Disord. 2005;11:S47-S51.
Not in our library10.1016/j.parkreldis.2004.10.014

All 66 references

Cited by papers we hold 4

Misfolded protein oligomers: mechanisms of formation, cytotoxic effects, and pharmacological approaches against protein misfolding diseases · 2024
No notice
Molecular Crowding: The History and Development of a Scientific Paradigm · 2024
No notice
TDP-43 forms amyloid filaments with a distinct fold in type A FTLD-TDP · 2023
No notice
Disease-specific tau filaments assemble via polymorphic intermediates · 2023
No notice

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.